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AbstrAct
Objective To investigate whether the health implications 
of having type 2 diabetes (T2D) were different in South 
Asian compared with white European participants.
Research design and methods Prospective data from 
UK Biobank were used, and 457 935 participants of white 
European and 7102 of South Asian background were 
included. Cox proportional regression was performed 
to investigate the association between T2D and health 
outcome by ethnicity.
Results Over a mean of 7.0 years (IQR 6.3–7.6) of follow- 
up, 12 974 participants had died, and 30 347 and 27 159 
developed cardiovascular disease (CVD) and cancer, 
respectively. South Asians had a higher risk for CVD 
mortality (HR: 1.42, 95% CI 1.07 to 1.89) and incidence 
(HR: 1.78, 95% CI 1.63 to 1.94), but a decreased risk 
for cancer mortality (HR: 0.59, 95% CI 0.41 to 0.85) and 
incidence (HR: 0.80, 95% CI 0.70 to 0.92) compared with 
white Europeans. Compared with individuals without T2D, 
both white Europeans and South Asians with T2D had a 
higher risk for all- cause mortality (1.59 (1.48 to 1.71) vs 
2.83 (1.76 to 4.53)), CVD mortality (2.04 (1.82 to 2.28) 
vs 4.40 (2.37 to 8.16)) and CVD incidence (1.37 (1.31 to 
1.44) vs 1.60 (1.31 to 1.95)), respectively. However, the 
magnitude of the risk was higher for South Asians than 
white Europeans.
Conclusions Although T2D was associated with a 
higher risk for all- cause mortality and CVD incidence and 
mortality, in both white Europeans and South Asians, the 
risk experienced by South Asians with T2D was higher than 
their white European counterparts.
InTROduCTIOn
Type 2 diabetes (T2D) more than doubles 
the risk of cardiovascular disease (CVD) 
and all- cause mortality.1 2 South Asians typi-
cally develop T2D 5–10 years earlier than 
white Europeans, transition through the 
‘pre- diabetes’ phase more rapidly, and once 
they develop diabetes disease progression 
is faster and microvascular complications 
develop more rapidly.3–5 Moreover, South 
Asians are at a twofold to sixfold increased 
risk of T2D compared with white Euro-
peans.6 7 It might, therefore, be expected 
significance of this study
What is already known about this subject?
 ► Type 2 diabetes (T2D) is a risk factor for all- cause 
mortality and cardiovascular disease (CVD) mortality 
and incidence.
 ► South Asians are at high risk for T2D compared with 
white Europeans living in the same country.
What are the new findings?
 ► South Asians had a higher risk for CVD incidence and 
mortality compared with white Europeans.
 ► The risk associated with having T2D was greater in 
South Asians compared with white Europeans for 
all- cause and CVD mortality and incidence.
 ► The excess CVD risk in South Asians, compared with 
white Europeans, was not fully explained by their 
higher T2D prevalence.
How might these results change the focus of 
research or clinical practice?
 ► A reduction in the prevalence of T2D has the largest 
potential impact among South Asians, and we there-
fore suggest that preventive measures that can pre-
vent or delay the onset of T2D may have the largest 
impact within the South Asian population.
 ► Further investigation is needed to underpin other 
risk factors that could play a key role in increasing 
CVD risk in South Asians.
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that T2D contributes to all- cause mortality and CVD to a 
larger extent in South Asians than in white Europeans. If 
so, the potential impact of T2D prevention among South 
Asians may be larger than among white Europeans.
It is already known that South Asians, as well as being 
at increased risk of T2D, are at increased risk for CVD.8 
But there is limited evidence as to whether the increased 
CVD risk among South Asians is due to the higher T2D 
prevalence and how all- cause mortality risk is influenced. 
There are few studies to date that have investigated 
mortality risk in South Asians and white Europeans with 
and without T2D.9–11 The results from these studies have 
been conflicting. A recent study showed that years of 
life lost due to T2D is higher among white Europeans 
than South Asians9; this was substantiated by another 
study by Shah et al10 that showed all- cause mortality risk 
to be lower in South Asians than in white Europeans. In 
contrast to this, a study by Tillin et al 11 showed that all- 
cause mortality risk is higher in South Asians compared 
with white Europeans with T2D, but the risk is similar 
between South Asians and white Europeans without 
T2D. These conflicting results may be due to differences 
in study design. The study by Shah et al10 did not adjust 
for important variables including smoking and adiposity 
measures. Furthermore, mortality risk may have changed 
over time due to improvements in healthcare; the study 
by Tillin et al11 was published recently, but the follow- up 
period started 20 years ago. The higher CVD mortality 
risk in South Asians may be balanced by a lower risk for 
cancer, as cancer and CVD together form the leading 
causes of death in high- income countries,12 13 resulting in 
no difference in all- cause mortality risk.
The aim of the current study was to compare the 
health risks associated with having T2D in South Asians 
and white Europeans. This was investigated for all- cause 
mortality, CVD and cancer mortality and incidence, both 
in terms of the increased risk associated with having T2D 
and the proportion of events attributable to T2D.
MeTHOds
Population
Between April 2007 and December 2010, the UK Biobank 
invited people aged 40–69 years old from the general 
population to participate in the study. From the initial 
invitations there was a 5.5% response rate,14 with 502 655 
participants finally agreeing to participate. Participants 
attended one of 22 assessment centers across England, 
Wales and Scotland15 16 where they completed a touch-
screen questionnaire, had physical measurements taken 
and provided biological samples, as described in detail 
later.15 16 Participants of white European (n=472 825) 
and South Asian (n=8024) ethnicity were considered. 
Participants who indicated to have been diagnosed with 
diabetes under the age of 30 were excluded to reduce 
the likelihood of including those with type 1 diabetes 
(1563 participants (1462 whites and 101 South Asians) 
were excluded on this basis), as shown previously.17 
Participants were only included in the total sample if the 
data that were provided were complete. Therefore, after 
the exclusion of participants who did not meet the spec-
ified criteria, 457 935 white Europeans and 7102 South 
Asians were considered in our analysis.
Procedures
Date of death was obtained from death certificates held by 
the National Health Service (NHS) Information Centre 
(England and Wales) and the NHS Central Register Scot-
land (Scotland). Date and cause of hospital admissions 
were identified via record linkage to Health Episode 
Statistics (England and Wales) and to the Scottish 
Morbidity Records (SMR01) (Scotland). Detailed infor-
mation regarding the linkage procedure can be found at 
http://www. ic. nhs. uk/ services/ medical- research- infor-
mation- service. At the time of analysis, mortality data were 
available up to 31 January 2016. Mortality analysis was 
therefore censored at these dates, or date of death if this 
occurred earlier. Hospital admission data were available 
until 31 March 2015, resulting in disease- specific analyses 
being censored at this date, or the date of hospital admis-
sion or death if this occurred earlier. CVD was defined as 
a hospital admission or death with International Classi-
fication of Diseases (ICD) 10th Revision code I05–I89.9 
(myocardial infarction, heart failure, stroke, atrial fibril-
lation, cerebrovascular diseases and circulatory diseases). 
Cancer was defined as an ICD code of C0.0–C9.9, D3.7–9 
or D4.0–8.
Measurements
Participants classified themselves into one of 16 ethnic 
groups consistent with the UK Office for National Statis-
tics Census categories. This study was restricted to partic-
ipants who classified themselves in one of the following 
groups: white European (British, Irish and other white 
European) or South Asian (Indian, Pakistani and Bangla-
deshi). Age was calculated from dates of birth and base-
line assessment. Area- based socioeconomic status was 
derived from postcode of residence using the Townsend 
score, which is derived from census data on housing, 
employment, social class and car availability.18 Other 
sociodemographic information such as professional qual-
ifications (college or university, A (advanced) or O (ordi-
nary) levels, General Certificate of Secondary Eduction 
(GCSE); or equivalent levels) and income (<£18 000, 
£18 000–29 999, £30 000–51 999, £52 000–100 000 and 
>£100 000) was self- reported at baseline.
Dietary information was collected via a self- reported 
dietary questionnaire (Oxford WebQ).19 20 Participants 
were asked how many portions of specified foods they 
generally ate. Subjective sleep duration was obtained 
by asking ‘About how many hours sleep do you get in 
every 24 hours?’ from which the following ordinal cate-
gories were derived: short sleeper <7 hours/day, normal 
sleeper 7–9 hours/day or long sleeper >9 hours/day. 
Physical activity was measured via the International Phys-
ical Activity Questionnaire (IPAQ) short form,21 with 
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participants reporting the frequency and duration of 
walking and moderate and vigorous activity undertaken 
in a typical week.21 Data were analyzed in accordance with 
the IPAQ scoring protocol,22 and total physical activity 
was computed as the sum of walking and moderate and 
vigorous activity, measured as metabolic equivalent- hours 
per week. Participants were excluded from the analyses if 
they recorded implausible values, defined as the sum of 
their total physical activity, sleeping time and total screen 
time exceeding 24 hours.23
Height, body weight and waist circumference were 
measured by trained nurses during the baseline assess-
ment. Body mass index (BMI) was calculated as (weight/
heigh2). Body fat percentage was measured using stan-
dardized bioimpedance protocols. Waist circumference 
was measured using standardized protocol. Further 
details of these measurements can be found in the UK 
Biobank online protocol (http://www. ukbiobank. ac. uk) 
and elsewhere.24
T2D was based on self- reported physician- diagnosed 
diabetes. Medical history (physician diagnosis of cancer, 
CVD, diabetes and hypertension) and medication history 
relating to diabetes, dyslipidemia and hypertension were 
collected from the self- completed baseline assessment 
questionnaire.
statistical analyses
Participants’ baseline characteristics by T2D status and 
ethnicity were presented as mean and SD for continuous 
variables and percentages and numbers of observations 
for categorical variables.
To investigate the association between T2D and health 
outcomes of interest (all- cause mortality and CVD and 
cancer incidence and mortality), Cox proportional hazard 
models with years of follow- up as the time- scale were 
performed and results presented as HR and their 95% 
CI. The proportional hazards assumption was checked by 
tests using the Schoenfeld residuals. Participants who self- 
reported having CVD (n=16 430 Europeans; n=367 South 
Asians) at baseline were excluded from the analyses when 
the outcome of interest was CVD. Similarly, when cancer 
was the outcome of interest, participants with a diagnosis 
of cancer (n=37 377 Europeans; n=249 South Asians) at 
baseline were excluded.
To investigate whether the hazard for health outcomes 
differs between white Europeans and South Asians, Cox 
regression analyses with white Europeans as the refer-
ence group were performed. To investigate whether the 
association between T2D and health outcomes differed 
by ethnicity, analyses were first carried out in each ethnic 
group separately, using individuals without T2D as the 
reference group. Following this it was tested whether the 
effect of T2D on health outcomes differed by ethnicity, by 
the addition of a multiplicative interaction term between 
T2D and ethnicity to the model.
Incremental adjustment for confounders were used; 
the models included age, sex, deprivation index, 
income and professional qualifications (model 0), and 
additionally smoking, red meat intake, processed meat 
intake, oily fish intake, fruit and vegetable intake, the 
frequency of alcohol intake, sedentary time, total phys-
ical activity, sleep duration and BMI (model 1). This 
was in accordance with a conceptual model developed 
with software from DAGgitty. The directed acyclic graph 
(DAG) is shown at  dagitty. net/ mvkWb2B and includes 
considered covariates (online supplementary figure 1).
Additionally, sensitivity analyses, where BMI was 
replaced by waist circumference and body fat percentage, 
as well as a mutually adjusted model to account for 
a potential fat distribution confounding effect, were 
conducted. Another sensitivity analysis was performed to 
assess if mortality risk between ethnic groups was similar 
when participants with T2D at baseline were excluded 
from all analyses.
Population attributable fractions (PAF) were calculated 
to estimate the proportions of mortality and morbidity 
outcomes attributed to T2D among white Europeans and 
South Asians. The potential impact fractions stratified 
by ethnicity were also determined for a 10%, 25%, 50% 
and 100% reduction in T2D prevalence. All analyses were 
performed using STATA V.15 statistical software and p 
values <0.05 were considered statistically significant.
ResulTs
Baseline characteristics
At baseline, 4.4% (n=20 068) of the included white Euro-
peans and 16.4% (n=1166) of the included South Asians 
had T2D (table 1). South Asian participants, both with 
and without T2D, were somewhat younger than white 
European participants. Although South Asians lived 
more often in deprived areas than white Europeans, a 
higher percentage of South Asians had a college or 
university degree compared with white Europeans. A 
higher percentage of white Europeans reported current 
or former smoking. Red and processed meat intake, as 
well as oily fish and alcohol intake, was higher in white 
Europeans than in South Asians. Fruit and vegetable 
intake, on the other hand, was higher among South 
Asians. Waist circumference was higher in South Asian 
participants without T2D, compared with white Euro-
pean participants without T2D. However, waist circum-
ference was higher in white European than South Asian 
participants when T2D was present.
Mortality, CVd and cancer risk by ethnicity
During a mean follow- up of 7.0 years (IQR 6.3–7.6), a total 
of 12 974 deaths occurred, 30 346 participants developed 
CVD and 27 159 developed cancer (online supplementary 
table S1). South Asians and white Europeans had similar 
rates of all- cause mortality (figure 1 and online supplemen-
tary table S1). However, in the minimally adjusted model 
(model 0), the hazards for CVD mortality and incidence 
were higher in South Asians than in white Europeans (HR 
1.73 (95% CI 1.31 to 2.29), p<0.0001 and HR 1.93 (95% 
CI 1.78 to 2.11), p<0.0001, respectively). The hazards for 
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Table 1 Baseline characteristics
White European 
without T2D
South Asian 
without T2D
White European with 
T2D
South Asian with 
T2D
Total participants 437 867 5936 20 068 1166
Age (years) 56.6 (8.0) 52.5 (8.4) 60.2 (6.8) 57.4 (7.9)
Sex (% male) 44.6 (195 302) 50.1 (2975) 61.3 (12 310) 62.5 (1166)
Deprivation index
  Lower (least deprived) 35.3 (154 382) 17.1 (1015) 28.4 (5691) 13.4 (156)
  Middle 34.3 (149 976) 27.3 (1618) 32.1 (6440) 27.4 (320)
  Higher (most deprived) 30.5 (133 509) 55.6 (3303) 39.6 (7937) 59.2 (690)
Income (£)
  <18 000 21.4 (81 024) 28.1 (1280) 36.2 (6189) 44.0 (376)
  18 000–51 999 52.0 (197 060) 45.5 (2069) 48.9 (8356) 39.9 (341)
  >52 000 26.7 (101 231) 26.4 (1201) 14.9 (2546) 16.1 (138)
Professional qualifications
  CSEs 6.2 (23 671) 7.1 (363) 5.5 (927) 7.6 (76)
  O- levels 24.7 (94 803) 18.4 (943) 23.9 (4043) 19.3 (194)
  A- levels 13.1 (50 154) 9.9 (507) 11.4 (1934) 8.1 (81)
  College/university degree 37.4 (143 468) 48.0 (2466) 26.7 (4521) 38.5 (386)
  None of the above 16.7 (371 714) 16.7 (855) 32.5 (5499) 26.5 (266)
Smoking
  Never 54.7 (239 392) 80.1 (4755) 42.2 (8477) 73.2 (853)
  Previous 35.0 (153 400) 11.4 (677) 47.0 (9432) 17.1 (199)
  Current 10.3 (45 075) 8.5 (504) 10.8 (2159) 9.8 (114)
Red meat intake (portions/week) 1.94 (1.38) 1.26 (1.48) 2.19 (1.56) 1.34 (1.66)
Processed meat intake (portions/week) 1.87 (1.05) 1.18 (1.17) 2.10 (1.03) 2.10 (1.03)
Oily fish intake (portions/week) 1.64 (0.92) 1.17 (1.04) 1.66 (0.96) 1.19 (1.11)
Fruit and vegetable intake (g/day) 325.9 (187.2) 397.3 (279.9) 343.4 (194.9) 436.3 (356.5)
Alcohol intake (% of TE) 2.84 (1.47) 4.55 (1.67) 3.38 (1.62) 4.82 (1.58)
Sedentary time (hours/day) 5.00 (2.26) 4.80 (2.73) 5.87 (2.61) 5.07 (2.94)
Physical activity (MET/day) 388.0 (540.7) 305.3 (441.9) 317.9 (490.3) 247.2 (393.0)
Physical activity recommendations
  Inactive 44.9 (196 496) 53.5 (3175) 55.9 (11 209) 60.4 (704)
  Active 55.1 (241 371) 46.5 (2761) 44.1 (8859) 39.6 (462)
Sleep duration (hours) 7.17 (1.06) 7.04 (1.17) 7.24 (1.32) 7.17 (1.36)
Height (cm) 168.6 (9.2) 163.8 (9.3) 169.6 (9.3) 164.3 (9.2)
Weight (kg) 77.5 (15.5) 72.4 (13.6) 91.2 (18.6) 77.9 (15.0)
BMI (kg/m2) 27.2 (4.6) 26.9 (4.3) 31.7 (5.9) 28.8 (5.0)
Waist circumference (cm) 89.5 (13.1) 90.1 (11.6) 103.5 (14.4) 97.7 (11.7)
Body fat (%) 31.2 (8.5) 31.7 (8.1) 34.1 (8.6) 32.7 (8.1)
Cancer diagnosed
  No 92.1 (402 429) 97.0 (5736) 90.6 (18 129) 96.4 (1117)
  Yes 7.9 (34 338) 3.0 (180) 9.4 (1883) 3.6 (42)
CVD diagnosed
  No 96.9 (432 802) 96.9 (5704) 88.3 (17 703) 89.2 (1031)
  Heart attack 1.9 (8499) 2.3 (133) 8.7 (1747) 8.3 (96)
  Stroke 1.1 (4940) 0.9 (50) 2.9 (589) 2.5 (29)
Data are mean and SD for continuous variables and percentages and numbers for categorical variables.
A, advanced; BMI, body mass index; CSE, Certificate of Secondary Education; CVD, cardiovascular disease; MET, metabolic equivalent; O, 
ordinary; T2D, type 2 diabetes; TE, total energy.
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Figure 2 Cox proportional hazard for all- cause mortality, 
CVD and cancer incidence and mortality by diabetes and 
ethnicity. * Participants without type 2 diabetes were used 
as the reference categories. Participants diagnosed with 
diabetes before the age of 30 years were removed from the 
analysis. Participants were included if they were free of CVD 
at baseline for CVD outcomes and free of cancer at baseline 
for cancer outcomes. The analyses were adjusted for age, 
sex, deprivation index, income, professional qualifications, 
smoking, red meat intake, processed meat intake, oily fish 
intake, fruit and vegetable intake, the frequency of alcohol 
intake, sedentary time, total physical activity, sleep duration 
and body mass index. The p value indicates differences 
within type 2 diabetes status. No significant interactions were 
found between type 2 diabetes and ethnicity for any of the 
health outcomes. CVD, cardiovascular disease.
Figure 1 Cox proportional hazard for all- cause mortality, 
CVD and cancer incidence and mortality by ethnicity. 
Participants of a white European background were used as 
the reference categories. Participants were included if they 
were free of CVD at baseline for CVD outcomes and free 
of cancer at baseline for cancer outcomes. The analyses 
were adjusted for age, sex, deprivation index, income, 
professional qualifications, smoking, red meat intake, 
processed meat intake, oily fish intake, fruit and vegetable 
intake, the frequency of alcohol intake, sedentary time, total 
physical activity, sleep duration and body mass index. CVD, 
cardiovascular disease.
cancer mortality and incidence were lower in South Asians 
than in white Europeans (HR 0.56 (95% CI 0.39 to 0.80), 
p=0.002 and HR 0.77 (95% CI 0.67 to 0.89), p<0.0001), 
respectively. Adjustment for T2D (model 2) attenuated 
the increased risk of CVD mortality among South Asians 
compared with white Europeans, and was fully attenuated 
in the sensitivity analyses which excluded participants with 
T2D (model 3). Adjustment or exclusion of participants 
with T2D did not change the observed higher risk for CVD 
or lower risk for cancer incidence among South Asians 
compared with white Europeans. However, the lower risk 
for cancer mortality observed in South Asians was attenu-
ated when participants with T2D were excluded (figure 1 
and online supplementary table S1). The adjustment for 
different adiposity markers (BMI, waist circumference, 
body fat) did not change the direction and magnitude 
of the associations, as presented in online supplementary 
table S3.
Mortality, CVd and cancer risk by T2d and ethnicity
The risk of all- cause mortality, CVD mortality, CVD inci-
dence and cancer mortality was, in both white Europeans 
and South Asians, higher in those with T2D compared 
with those without T2D (figure 2 and online supplemen-
tary table S2). Although there were no significant inter-
actions between T2D and ethnicity for health outcomes 
(p>0.05), the associations were somewhat stronger among 
South Asians with T2D, compared with white Europeans 
with T2D, for all- cause mortality and CVD mortality and 
incidence. Compared with participants without T2D, the 
hazard for CVD mortality was 1.99 (95% CI 1.79 to 2.21) 
in white Europeans with T2D, whereas South Asians with 
T2D had a hazard of 4.26 (95% CI 2.32 to 7.80). Similar 
results were observed for all- cause mortality (HR: 1.62 
(95% CI 1.53 to 1.72) vs 2.46 (95% CI 1.67 to 3.63)) and 
CVD incidence (HR: 1.36 (95% CI 1.31 to 1.43) vs 1.62 
(95% CI 1.33 to 1.97)) in people with T2D of white Euro-
pean and South Asian ethnicities, respectively (figure 2 
and online supplementary table S2). Further adjustment 
for waist circumference or body fat percentage did not 
Protected by copyright.
 o
n
 February 15, 2020 at University of G
lasgow.
http://drc.bmj.com/
BM
J O
pen Diab Res Care: first published as 10.1136/bmjdrc-2019-000765 on 17 December 2019. Downloaded from 
6 BMJ Open Diab Res Care 2019;7:e000765. doi:10.1136/bmjdrc-2019-000765
Epidemiology/Health Services Research
Table 2 Proportion of events attributable to diabetes in South Asians and white Europeans
All- cause mortality CVD mortality CVD incidence
Estimate
95% CI
Estimate
95% CI
Estimate
95% CI
Lower 
limit
Upper 
limit
Lower 
limit
Upper 
limit
Lower 
limit
Upper 
limit
White
  Risk ratio 1.53 1.42 1.65 1.89 1.69 2.13 1.27 1.22 1.33
  Population attributable 
fraction
2.05 1.59 2.48 3.40 2.56 4.18 1.06 0.83 1.27
  Potential impact 
fraction
  10% reduction in 
diabetes prevalence
0.25 0.18 0.31 0.45 0.31 0.56 0.12 0.09 0.14
  25% reduction in 
diabetes prevalence
0.60 0.45 0.73 1.06 0.72 1.34 0.29 0.22 0.35
  50% reduction in 
diabetes prevalence
1.13 0.87 1.39 1.97 1.43 2.45 0.56 0.43 0.68
South Asian
  Risk ratio 3.27 2.00 5.36 4.30 2.27 8.14 1.63 1.33 2.00
  Population attributable 
fraction
25.36 11.02 37.50 33.04 14.78 49.44 8.65 4.11 12.88
  Potential impact 
fraction
  10% reduction in 
diabetes prevalence
4.08 0.40 6.42 5.84 0.57 9.65 1.07 0.34 1.64
  25% reduction in 
diabetes prevalence
9.37 1.73 14.59 13.16 1.97 21.13 2.58 0.97 3.92
  50% reduction in 
diabetes prevalence
16.33 3.99 24.79 22.29 6.33 35.57 4.85 1.76 7.27
Participants were included if they were free of CVD at baseline for CVD outcomes. The analyses were adjusted for age, sex, deprivation 
index, income, professional qualifications, smoking, red meat intake, processed meat intake, oily fish intake, fruit and vegetable intake, the 
frequency of alcohol intake, sedentary time, total physical activity, sleep duration and body mass index.
CVD, cardiovascular disease.
change the direction and magnitude of the associations, 
as presented in online supplementary table S4.
Potential impact of T2d prevention
Modeling the impact of a reduction in T2D prevalence 
showed that T2D contributed to all- cause mortality, CVD 
mortality and CVD incidence in both South Asians and 
white Europeans (table 2). However, due to its high 
prevalence among South Asians, T2D contributed to a 
greater extent to all- cause mortality, CVD mortality and 
CVD incidence in South Asians compared with white 
Europeans. For example, a reduction in T2D prevalence 
of 50% resulted in an estimated 1.97% (95% CI 1.43% 
to 2.45%) and 22.29% (95% CI 6.33% to 35.57%) reduc-
tion in the CVD mortality in white Europeans and South 
Asians, respectively.
dIsCussIOn
The results of this study confirm the increased risk of 
all- cause mortality and CVD mortality and incidence 
in participants with T2D. Although the findings of this 
study did not show a significant interaction of T2D and 
ethnicity with health outcomes, the risks associated with 
having T2D were greater in South Asians compared with 
white Europeans for all- cause and CVD mortality and 
incidence. T2D appears to be a stronger risk factor for 
all- cause mortality, CVD and cancer mortality and inci-
dence among South Asians (Relative Risk (RR) 1.63–
4.30) than white Europeans (RR 1.27–1.89). This was 
further compounded by the higher T2D prevalence in 
South Asians, rendering the potential impact of T2D 
reduction being greater in South Asians compared with 
white Europeans.
Both white European and South Asian participants 
had a relatively similar risk of all- cause mortality. This is 
thought to be because the higher risk of mortality due 
to CVD among South Asians is counterbalanced by the 
lower cancer risk. Previous studies have not reached a 
consensus on this matter. Shah et al10 suggested that the 
mortality risk in people with T2D was lower among South 
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Asians when compared with white Europeans. However, 
the Shah et al10 study included participants who had 
recently been diagnosed with T2D. This was in contrast 
to the current study, where we included participants who 
had already been diagnosed with T2D at baseline. There-
fore, participants within the current study had a longer 
duration of T2D. Additionally, the study by Shah et al10 did 
not adjust for smoking or adiposity levels,25 with smoking 
rates generally much lower (as is also the case in this 
study) among South Asians compared with white Euro-
peans. Study settings may also have led to the contrasting 
results, with the current study conducted in the UK and 
the study by Shah et al10 conducted in Canada. Differ-
ences including those related to healthcare may have led 
to the observed study differences.
The results of the current study agree with the findings 
from a previous study conducted in the UK by Tillin et 
al,11 which suggested that the risk of CVD is higher in 
South Asians, relative to white Europeans, with T2D but 
not those without T2D. Although results from the study 
of Tillin et al11 were published recently, follow- up started 
between 1988 and 1991. It was speculated therefore 
that over time mortality risk may have changed due to 
an improvement in CVD management.26 In addition, in 
past decades greater attention has been paid to the differ-
ences in disease risk between ethnicities within health-
care, for example, in diabetes screening. It is, however, 
interesting to note that, according to the current study, 
these changes have not affected the higher CVD and all- 
cause mortality risk among South Asians compared with 
white Europeans.
In accordance with previous studies, this study reported 
differences in CVD and cancer risk between white Euro-
pean and South Asian participants.11 25 26 In the future, it 
might be important to consider that when the high CVD 
risk among South Asians is better managed in these popu-
lations, this may impact on cancer risk. The higher risk 
for CVD mortality may partly result in the lower cancer 
mortality among South Asians, but if CVD mortality was 
lowered in South Asians then the risk of developing 
cancer due to a higher life expectancy may increase. 
On the other hand, South Asians may have a high prev-
alence of genetic polymorphisms that are protective of 
cancer, suggesting that the low cancer risk may actually 
be conserved in the case that the interplay with environ-
mental risk factors is not changed.27
Adjustment for T2D only partially explained the 
increased risk of CVD mortality among South Asians 
compared with white Europeans for CVD mortality. 
However, sensitivity analyses were used to exclude 
participants with T2D, which resulted in the full atten-
uation of the higher risk for CVD mortality in South 
Asians. However, it cannot be discarded that this may be 
attributable to our limited power to detect an associa-
tion when T2D cases were excluded. In contrast to this 
finding, the excess CVD incidence risk in South Asians, 
compared with white Europeans, was not altered after 
the adjustment for T2D or exclusion of T2D cases from 
the analyses, resulting in a slight attenuation of the CVD 
risk.
Although this study provides evidence that T2D may 
not fully explain the higher CVD risk experienced by 
South Asians, further investigation is needed to underpin 
the risk factors that could play a key role in the increased 
T2D and CVD risk in South Asians. Especially since T2D 
and CVD share common denominators that may explain 
both the increased risk T2D and CVD risk,28 preventive 
measures for T2D may also impact on CVD risk indepen-
dent of its development through T2D. Unfortunately, the 
underlying causes for the higher susceptibility to both 
CVD and T2D among South Asians compared with other 
populations remain unclear despite many hypotheses, 
mainly related to socioeconomic, genetic, developmental 
and lifestyle factors, having been investigated.29 However, 
preventive measures could still target known risk factors 
that impact T2D risk among both South Asians and white 
Europeans, such as dietary intake and physical activity.30
Our PAF analyses highlight that the contribution of 
T2D to the CVD incidence and mortality in the general 
population is larger among South Asians than among 
white Europeans due to the higher prevalence of T2D 
in South Asians than in white Europeans. A reduction in 
the prevalence of T2D had the largest potential impact 
among South Asians, and therefore we suggest that 
preventive measures to prevent or delay the onset of 
T2D may have the largest impact within the South Asian 
population.
limitations
This study is not exempt from limitations. First, the diag-
nosis of T2D within the current study was based on self- 
reporting of physician- diagnosed T2D. This may have 
biased our results as some participants may not recall their 
diagnosis accurately, at all, or may not want to report it. 
This bias may be greater if self- reporting was more accu-
rate in one ethnic group compared with others. Further-
more, screening rates for T2D may be different among 
ethnic groups due to ethnic differences in the prevalence 
of T2D. However, previous studies using UK Biobank 
have shown that the use of self- reported diabetes is a valid 
method and can distinguish between participants with 
and without diabetes.31 Moreover, studies on the validity 
of self- reported physician- diagnosed diabetes have shown 
both excellent positive and negative predictive value.32 
In addition, misclassification of the type of diabetes was 
limited by excluding participants with diabetes diagnosed 
under the age of 30 years. Second, analyses were adjusted 
for confounders in accordance with the DAG. It can, 
however, not be excluded that analyses were overadjusted 
for confounders. This may have partly led to filtering out 
the direct effect of T2D on mortality. Third, participants 
included in the UK Biobank study may not be a represen-
tative sample of the British population due to ‘healthy 
volunteer’ selection bias.33 Therefore, future studies are 
needed to confirm the findings in representative popula-
tions of the UK but also in other countries where South 
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Asians represent a greater proportion of the population. 
Finally, South Asian populations consist of a very hetero-
geneous group of people with a wide variety of popula-
tion characteristics. Heterogeneity exists both in genetic 
etiology and in lifestyle factors depending on ancestral 
background. Since diabetes is a common factor affecting 
all South Asian populations, the different underlying 
populations were studied together, but in future studies 
subpopulation- specific figures may be calculated.
COnClusIOn
In conclusion, South Asians have a higher risk of CVD 
mortality and incidence but a lower risk of cancer 
mortality and incidence compared with white Europeans. 
Although T2D was associated with a higher risk for all- 
cause mortality and CVD incidence and mortality, in both 
white Europeans and South Asians, the risk experienced 
by South Asians with T2D was higher than their white 
European counterparts.
Author affiliations
1Department of Public Health, Amsterdam Public Health Research Institute, 
Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands
2BHF Glasgow Cardiovascular Research Centre, Institute of Cardiovascular and 
Medical Sciences, University of Glasgow, Glasgow, UK
3Institute of Health and Wellbeing, University of Glasgow, Glasgow, UK
4Centre for Research in Exercise Physiology (CIFE), Universidad Mayor, Santiago, 
Chile
Acknowledgements We are grateful to UK Biobank participants. This research 
has been conducted using the UK Biobank Resource under application number 
7155. UK Biobank was established by the Wellcome Trust medical charity, Medical 
Research Council, Department of Health, Scottish Government, and the Northwest 
Regional Development Agency, and is funded by the Welsh Government and the 
British Heart Foundation.
Contributors MM, FH, HW, AS, PW, SI, RB, LF, KS, IvV, JPP, SRG, JMRG, NS, and 
CC- M reviewed the manuscript and approved the final version to be published. 
MM, FH, and CC- M performed the statistical analyses. MM, FH, JMRG, NS, and 
CC- M contributed to the study conception and design, advised on all statistical 
aspects, and interpreted the data. MM, FH, and CC- M drafted the manuscript. MM, 
FH, JPP, NS, JMRG, and CC- M are the guarantors of this work, and as such had full 
access to all the data in the study and take responsibility for the integrity of the 
data and the accuracy of the data analysis.
Funding This work was supported by the Health Behaviours & Chronic Diseases, 
Amsterdam Public Health. MM received a travel grant.
Competing interests None declared.
Patient consent for publication Not required.
ethics approval The UK Biobank study was approved by the North West Multi- 
Centre Research Ethics Committee, and all participants provided written informed 
consent to participate in the UK Biobank study. The study protocol is available online 
(http://www. ukbiobank. ac. uk/).
Provenance and peer review Not commissioned; externally peer reviewed.
data availability statement Data may be obtained from a third party and are not 
publicly available.
Open access This is an open access article distributed in accordance with the 
Creative Commons Attribution Non Commercial (CC BY- NC 4.0) license, which 
permits others to distribute, remix, adapt, build upon this work non- commercially, 
and license their derivative works on different terms, provided the original work is 
properly cited, appropriate credit is given, any changes made indicated, and the 
use is non- commercial. See: http:// creativecommons. org/ licenses/ by- nc/ 4. 0/.
ORCId ids
Mirthe Muilwijk http:// orcid. org/ 0000- 0002- 3686- 5116
Heather Waddell http:// orcid. org/ 0000- 0001- 5845- 4804
Paul Welsh http:// orcid. org/ 0000- 0002- 7970- 3643
Stamatina Iliodromiti http:// orcid. org/ 0000- 0001- 6453- 6654
Stuart Robert Gray http:// orcid. org/ 0000- 0001- 8969- 9636
Carlos Celis- Morales http:// orcid. org/ 0000- 0003- 2612- 3917
RefeRences
 1 Laakso M. Cardiovascular disease in type 2 diabetes from 
population to man to mechanisms: the Kelly West Award Lecture 
2008. Diabetes Care 2010;33:442–9.
 2 Sarwar N, Gao P, Seshasai SRK, et al. Diabetes mellitus, fasting 
blood glucose concentration, and risk of vascular disease: a 
collaborative meta- analysis of 102 prospective studies. Lancet 
2010;375:2215–22.
 3 Gujral UP, Pradeepa R, Weber MB, et al. Type 2 diabetes in South 
Asians: similarities and differences with white Caucasian and other 
populations. Ann N Y Acad Sci 2013;1281:51–63.
 4 Gupta R, Misra A. Epidemiology of microvascular complications of 
diabetes in South Asians and comparison with other ethnicities. J 
Diabetes 2016;8:470–82.
 5 Admiraal WM, Holleman F, Snijder MB, et al. Ethnic disparities 
in the association of impaired fasting glucose with the 10- year 
cumulative incidence of type 2 diabetes. Diabetes Res Clin Pract 
2014;103:127–32.
 6 Meeks KAC, Freitas- Da- Silva D, Adeyemo A, et al. Disparities in 
type 2 diabetes prevalence among ethnic minority groups resident in 
Europe: a systematic review and meta- analysis. Intern Emerg Med 
2016;11:327–40.
 7 Banerjee AT, Shah BR. Differences in prevalence of diabetes among 
immigrants to Canada from South Asian countries. Diabet Med 
2018;35:937–43.
 8 Rana A, de Souza RJ, Kandasamy S, et al. Cardiovascular risk 
among South Asians living in Canada: a systematic review and 
meta- analysis. CMAJ Open 2014;2:E183–91.
 9 Wright AK, Kontopantelis E, Emsley R, et al. Life expectancy and 
cause- specific mortality in type 2 diabetes: a population- based 
cohort study quantifying relationships in ethnic subgroups. Diabetes 
Care 2017;40:338–45.
 10 Shah BR, Victor JC, Chiu M, et al. Cardiovascular complications 
and mortality after diabetes diagnosis for South Asian and 
Chinese patients: a population- based cohort study. Diabetes Care 
2013;36:2670–6.
 11 Tillin T, Hughes AD, Mayet J, et al. The relationship between 
metabolic risk factors and incident cardiovascular disease in 
Europeans, South Asians, and African Caribbeans: sabre (Southall 
and Brent revisited) -- a prospective population- based study. J Am 
Coll Cardiol 2013;61:1777–86.
 12 Heron M, Anderson RN. Changes in the leading cause of death: 
recent patterns in heart disease and cancer mortality. NCHS Data 
Brief 2016:1–8.
 13 GBD 2017 Causes of Death Collaborators. Global, regional, and 
national age- sex- specific mortality for 282 causes of death in 195 
countries and territories, 1980-2017: a systematic analysis for the 
global burden of disease study 2017. Lancet 2018;392:1736–88.
 14 Fox CS, Sullivan L, D'Agostino RB, et al. The significant effect 
of diabetes duration on coronary heart disease mortality: the 
Framingham heart study. Diabetes Care 2004;27:704–8.
 15 Palmer LJ. Uk Biobank: bank on it. Lancet 2007;369:1980–2.
 16 Sudlow C, Gallacher J, Allen N, et al. Uk Biobank: an open access 
resource for identifying the causes of a wide range of complex 
diseases of middle and old age. PLoS Med 2015;12:e1001779.
 17 Ferguson LD, Ntuk UE, Celis- Morales C, et al. Men across a range 
of ethnicities have a higher prevalence of diabetes: findings from a 
cross- sectional study of 500 000 UK Biobank participants. Diabetic 
Medicine 2018;35:270–6.
 18 Townsend P, Phillimore M, Beattie A. Health and deprivation: 
inequality and the North. London: Croom Helm Ltd, 1988.
 19 Galante J, Adamska L, Young A, et al. The acceptability of repeat 
Internet- based hybrid diet assessment of previous 24- h dietary 
intake: administration of the Oxford WebQ in UK Biobank. British 
Journal of Nutrition 2016;115:681–6.
 20 Anderson JJ, Celis- Morales CA, Mackay DF, et al. Adiposity among 
132 479 UK Biobank participants; contribution of sugar intake vs 
other macronutrients. Int J Epidemiol 2017;46:492–501.
 21 Guo W, Bradbury KE, Reeves GK, et al. Physical activity in relation to 
body size and composition in women in UK Biobank. Ann Epidemiol 
2015;25:406–13.
 22 IPAQ. Guidelines for Data Processing and Analysis of the 
International Physical Activity Questionnaire (IPAQ) - Short 
Form,Version 2.0. IPAQ, 2004. www. ipaq. ki. se
Protected by copyright.
 o
n
 February 15, 2020 at University of G
lasgow.
http://drc.bmj.com/
BM
J O
pen Diab Res Care: first published as 10.1136/bmjdrc-2019-000765 on 17 December 2019. Downloaded from 
9BMJ Open Diab Res Care 2019;7:e000765. doi:10.1136/bmjdrc-2019-000765
Epidemiology/Health Services Research
 23 Celis- Morales CA, Lyall DM, Anderson J, et al. The association 
between physical activity and risk of mortality is modulated by grip 
strength and cardiorespiratory fitness: evidence from 498 135 UK- 
Biobank participants. Eur Heart J 2016;386:ehw249–22.
 24 Iliodromiti S, Celis- Morales CA, Lyall DM, et al. The impact of 
confounding on the associations of different adiposity measures with 
the incidence of cardiovascular disease: a cohort study of 296 535 
adults of white European descent. Eur Heart J 2018;39:1514–20.
 25 Tillin T, Sattar N, Forouhi N, et al. Comment on Shah et al. 
Cardiovascular complications and mortality after diabetes diagnosis 
for South Asian and Chinese patients: a population- based 
cohort study. Diabetes care 2013;36:2670-2676. Diabetes Care 
2014;37:e78–9.
 26 Johns E, Sattar N. Cardiovascular and mortality risks in migrant 
South Asians with type 2 diabetes: are we winning the battle? Curr 
Diab Rep 2017;17:100.
 27 Vettriselvi V, Vijayalakshmi K, Solomon PFD, et al. Xrcc1 and XPD 
gene polymorphisms in a South Indian population. Asian Pac J 
Cancer Prev 2007;8:283–6.
 28 De Rosa S, Arcidiacono B, Chiefari E, et al. Type 2 diabetes mellitus 
and cardiovascular disease: genetic and epigenetic links. Front 
Endocrinol 2018;9:2.
 29 Bhopal RS. Epidemic of cardiovascular disease and diabetes 
explaining the phenomenon in South Asians worldwide. Oxford, 2019.
 30 Jenum AK, Brekke I, Mdala I, et al. Effects of dietary and physical 
activity interventions on the risk of type 2 diabetes in South Asians: 
meta- analysis of individual participant data from randomised 
controlled trials. Diabetologia 2019;62:1337–48.
 31 Eastwood SV, Mathur R, Atkinson M, et al. Algorithms for the 
capture and adjudication of prevalent and incident diabetes in UK 
Biobank. PLoS One 2016;11:e0162388.
 32 Pastorino S, Richards M, Hardy R, et al. Validation of self- reported 
diagnosis of diabetes in the 1946 British birth cohort. Prim Care 
Diabetes 2015;9:397–400.
 33 Swanson JM. The UK Biobank and selection bias. Lancet 
2012;380:110–10.
Protected by copyright.
 o
n
 February 15, 2020 at University of G
lasgow.
http://drc.bmj.com/
BM
J O
pen Diab Res Care: first published as 10.1136/bmjdrc-2019-000765 on 17 December 2019. Downloaded from 
